Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × abemaciclib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 60 Neoplasm Metastasis 13 Brain Neoplasms 9 Endometrial Neoplasms 8 Prostatic Neoplasms 7 Glioblastoma 7 Ovarian Neoplasms 6 Neoplasms 6 Triple Negative Breast Neoplasms 5 Sarcoma 4 Glioma 4 Recurrence 3 Meningioma 3 Carcinoma, Non-Small-Cell Lung 3 Unilateral Breast Neoplasms 2 Sarcoma, Ewing 2 Osteosarcoma 2 Neoplasms by Site 2 Liposarcoma 2 Fallopian Tube Neoplasms 2 Ependymoma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Breast Diseases 2 Venous Thromboembolism 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1

Interventions

Specimen Handling 7 Biopsy 6 Cyclophosphamide 5 ruxolitinib 4 Mycophenolic Acid 4 Busulfan 4 fludarabine phosphate 3 fludarabine 3 Whole-Body Irradiation 3 Tacrolimus 3 Melphalan 3 Injections 3 Decitabine 3 Cyclosporine 3 Azacitidine 3 venetoclax 2 decitabine and cedazuridine drug combination 2 Sirolimus 2 Methotrexate 2 Granulocyte Colony-Stimulating Factor 2 veliparib 1 tocilizumab 1 tagraxofusp 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 merphos 1 iadademstat 1 gilteritinib 1 fedratinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡